Postoperative radiotherapy for patients with invasive cervical cancer following treatment with simple hysterectomy

Japanese Journal of Clinical Oncology

Volumn 33, Issue 9, 2003, Pages 477-481

  Chen, Shang Wen ^a,b   Liang, Ji An ^a,b   Yang, Shih Neng ^a,b   Lin, Fang Jen ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Adjuvant radiotherapy; Cervical carcinoma; Simple hysterectomy

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLADDER DISEASE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; LYMPH VESSEL; MAJOR CLINICAL STUDY; METASTASIS; MYOMETRIUM; PATHOLOGY; PATIENT REFERRAL; PATIENT SELECTION; PELVIS; POSTOPERATIVE CARE; RADIATION DOSE; RADIATION FIELD; RADIOLOGY DEPARTMENT; RECTUM DISEASE; RETROSPECTIVE STUDY; STROMA; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR EMBOLISM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VAGINA CANCER; ADENOCARCINOMA; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; MEGAVOLTAGE RADIOTHERAPY; MIDDLE AGED; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0642310635     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg086     Document Type: Article

References (20)

1. Hatch KD. Cervical Cancer. In: Berek JS, Hacker NF, editors. Practical Gynecologic Oncology, 2nd ed. Baltimore: Williams & Wilkins, 1994; 249.
2. Perez CA. Uterine Cervix: Principles and Practice of Radiation Oncology, 3rd ed. Philadelphia: Lippincott-Raven 1998;1752-3.
3. Ampil F, Datta R, Datta S. Elective postoperative external radiotherapy after hysterectomy in early stage carcinoma of cervix: Is additional vaginal cuff irradiation necessary? Cancer 1997;60:280-8.
4. Andras EJ, Fletcher GH, Rutledge F. Radiotherapy of carcinoma following simple hysterectomy. Am J Obstet Gynecol 1973;115:647-55.
5. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31: 1341-6.
6. Perkins PL, Chu AM, Jose B, Achino E, Tobin DA. Posthysterectomy megavoltage irradiation in the treatment of cervical carcinoma. Gynecol Oncol 1984;17:340-8.
7. Papavasilious C, Yiagarakis D, Pappas J, Keramopoulos A. Treatment of cervical carcinoma by total hysterectomy and postoperative external irradiation. Int J Radiat Oncol Biol Phys 1980;6:871-4.
8. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340:1137-43.
9. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1143-53.
10. Perez CA, Camel HM, Askin F, Breaux S. Endometrial extension of carcinoma of uterine cervix: A prognostic factor that may modify staging. Cancer 1981;48:170-80.
11. Fioricca JV, Roberts WS, Greenberg H, Hoffman MS, LaPolla JP, Cavanagh D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990;36:343-7.
12. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW. Complications of combined radical hysterectomy and postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989;32:292-6.
13. Cunningham MJ, Dunton CJ, Corn B, Noumoff J, Morgan MA, King S, et al. Extended field radiation therapy in early-stage cervical carcinoma: survival and complications. Gynecol Oncol 1991;43:51-4.
14. Kridelka FJ, Berg DO, Neuman M, Edwards LS, Robertson G, Grant PT, et al. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. Cancer 1999;86:2059-65.
15. Bohm JW, Kruoo PJ, Lee FYL, Batson HW. Lymph node metastases in microinvasive epidermoid cancer of the cervix. Obstet Gynecol 1976;48: 65-7.
16. Eifel PJ. High-dose-rate brachytherapy for carcinoma of the cervix. High tech or high risk? Int J Radiat Oncol Biol Phys 1992;24:383-6.
17. Fowler JF. Review article - The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
18. Chen SW, Liang JA, Yang SN, Liu RT, Lin FJ. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2000;47:955-61.
19. Smith HO, Quall CR, Romero AA, Webb JC, Dorin MH, Padilla LA, Key CR. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix? Gynecol Oncol 2002;85:229-41.
20. Schorge JO, Lee KR, Flynn CE, Goodman A, Sheets EE. Stage IA1 cervical adenocarcinoma: Definition and treatment. Obstet Gynecol 1999;93: 219-22.